El escándalo de las vacunas VIP en Argentina llegó a The New York Times
El prestigioso medio estadounidense se hizo eco de la aplicación irregular de dosis y de la renuncia forzada de Ginés González García, quien “fue acusado de abuso de poder”. “Vacunación VIP para los poderosos y sus compinches sacude a Sudamérica”, se tituló el artículo
/cloudfront-us-east-1.images.arcpublishing.com/infobae/XDTUPSZJLJAPBGYURZ35FVLVYE.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/ZVDVOOYZMZC4RINOFBDRRFKCMY.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/IYYDM6YZERD3BCDHLHGTNPOD6E.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/T6GENR5TKZCRTFVM4POPJOC26U.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/QY5LLRDXVJE27OKE72G7I7VQBA.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/CID4NUV6TNFKTAMXKPJ5JMFSFI.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/YEZQJ2ODQNCLRN3MYG6AHVJOGM.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/L6YBA5AJMZC6TOXG63RRCUZTOM.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/UQB5HYFKQVSEXY3QUUZFLX2I4Y.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/BER7HIHQRJBKXNC73NQEO3ZDBQ)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/Y76NKNGMHBF7XFGY5YR2SQTLJU)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/2NRG7CGSBC4J2L2FON2FDC7GYQ.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/G5ELLKBW3RCBHDW3U3JMTKDFRE.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/Z2V7R7OLZFHKNXIW26ULPMSSRM.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/VXUQBSBRHF4KBKOSQG7B2L54FI.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/JQQVFD3W55AC5PKTON46HCWFNE.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/GVKQE72BPRDZTJU3KOCQUWG3MQ.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/RXGO4M6MGVHBTOTVR27KBJALYY.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/MZMTT5NRNNCNHLN62WL3PUEI3U.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/N3FLEJIYWBDMZH2CR6S57EWZ4M.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/6FI6UNH4WJGI7IT76423GRWTJU.jpeg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/IVD5Z2BQOJHXHIHSKY7MLBJBBE.jpeg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/FXOLSM3BIVAILGCIFXI37JB5QQ.jpeg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/ZRAELABRBBEFLMM5CABI3HRJKI.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/TALQZ3GRK5FZTC665PNTA7G24A.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/TSSPDRF7ARFEHDAACBM7TKEPPQ.jpeg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/XSXYNUHTHBBLVDR6XYSXYNPHXI.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/RXGO4M6MGVHBTOTVR27KBJALYY.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/Y76NKNGMHBF7XFGY5YR2SQTLJU)